Shares of Heartware (HTWR) halted ahead of FDA Advisory meeting
Tweet
Share
E-mailGet Alerts HTWR Hot Sheet
Join SI Premium – FREE
Shares of Heartware (Nasdaq: HTWR) halted ahead of FDA Advisory meeting.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA authorizes 11 ZYN Ultra nicotine pouches for Philip Morris
- Radiopharm trial advances to higher dose in HER2+ cancer study
- FDA clears Implantica's RefluxStop implant for U.S. market
Create E-mail Alert Related Categories
FDA, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
